Immunomodulation by thalidomide and thalidomide analogues (original) (raw)

Differential cytokine modulation and T cell activation by two distinct classes of thalidomide analogues that are potent inhibitors of TNF-alpha

Laura G. Corral

Journal of immunology (Baltimore, Md. : 1950), 1999

View PDFchevron_right

Differential Cytokine Modulation and T Cell Activation by Two Distinct Classes of Thalidomide Analogues That Are Potent Inhibitors of TNF-α

Gilla Kaplan

The Journal of Immunology, 1999

View PDFchevron_right

Discovering a new analogue of thalidomide which may be used as a potent modulator of TNF-α production

Gema Dominguez

European Journal of Medicinal Chemistry, 2009

View PDFchevron_right

TNF{alpha} That Are Potent Inhibitors of Classes of Thalidomide Analogues T Cell Activation by Two Distinct Differential Cytokine Modulation and

Gilla Kaplan

View PDFchevron_right

Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes

Gilla Kaplan

Journal of Experimental Medicine, 1991

View PDFchevron_right

Selection of novel analogs of thalidomide with enhanced tumor necrosis factor α inhibitory activity

Laura G. Corral

Molecular Medicine

View PDFchevron_right

Amino-substituted thalidomide analogs: Potent inhibitors of TNF-α production

Gilla Kaplan

Bioorganic & Medicinal Chemistry Letters, 1999

View PDFchevron_right

Inhibitors of TNF-Thalidomide Analogues That Are Potent Activation by Two Distinct Classes of Differential Cytokine Modulation and T Cell

Laura G. Corral

1999

View PDFchevron_right

Enantioselective inhibition of TNF‐α release by thalidomide and thalidomide‐analogues

Kai Zwingenberger

Chirality, 1996

View PDFchevron_right

Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation

Gilla Kaplan

Journal of Experimental Medicine, 1993

View PDFchevron_right

Thalidomide analogues: Tumor necrosis factor-alpha inhibitors and their evaluation as anti-inflammatory agents

Juan Casal

View PDFchevron_right

Thalidomide Suppressed IL-1β While Enhancing TNF-α and IL-10, When Cells in Whole Blood were Stimulated with Lipopolysaccharide

felipe sandoval

Immunopharmacology and Immunotoxicology, 2008

View PDFchevron_right

Enantioselective inhibition of TNF? release by thalidomide and thalidomide-analogues

Kai Zwingenberger

Chirality, 1996

View PDFchevron_right

5′-Substituted Thalidomide Analogs as Modulators of TNF

Kai Zwingenberger

Archiv Der Pharmazie, 1998

View PDFchevron_right

Thalidomide analogs and PDE4 inhibition

Laura G. Corral

Bioorganic & Medicinal Chemistry Letters, 1998

View PDFchevron_right

Enhancement of Cytokine Production and AP-1 Transcriptional Activity in T Cells by Thalidomide-Related Immunomodulatory Drugs

Faribourz Payvandi

Journal of Pharmacology and Experimental Therapeutics, 2003

View PDFchevron_right

Pharmacological Properties of Thalidomide and its Analogues

Reinaldo Compagnone, Michael Mijares, Juan Sanctis

Recent Patents on Inflammation & Allergy Drug Discovery, 2010

View PDFchevron_right

Thalidomide exerts its inhibitory action on tumor necrosis factor by enhancing mRNA degradation

Andre Moreira

View PDFchevron_right

Thalidomide inhibits lipopolysaccharide-induced tumor necrosis factor-α production via down-regulation of MyD88 expression

Shafiqul Islam

Innate immunity, 2009

View PDFchevron_right

Recent Developments of Thalidomide Derivatives Possessing Anti-Inflammatory Activity

Hulya Akgun

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, 2010

View PDFchevron_right

Mono- and Dihydroxylated Metabolites of Thalidomide: Synthesis and TNF-.ALPHA. Production-Inhibitory Activity

Rishav Raj

Chemical and Pharmaceutical Bulletin, 2006

View PDFchevron_right

Thalidomide Costimulates Primary Human T Lymphocytes, Preferentially Inducing Proliferation, Cytokine Production, and Cytotoxic Responses in the CD8+ Subset

Gilla Kaplan

Journal of Experimental Medicine, 1998

View PDFchevron_right

A Single Oral Dose of Thalidomide Enhances the Capacity of Lymphocytes to Secrete Gamma Interferon in Healthy Humans

Peter Speelman

Antimicrobial Agents and Chemotherapy, 2000

View PDFchevron_right

Immunomodulatory effects of thalidomide analogs on LPS-induced plasma and hepatic cytokines in the rat

Víctor Pérez-Alvarez

Biochemical Pharmacology, 2004

View PDFchevron_right

Thalidomide-based TNF-alpha inhibitors for neurodegenerative diseases

Nigel Greig

Acta neurobiologiae experimentalis, 2004

View PDFchevron_right

Thalidomide in immunosuppressors and anti-TNF unresponsive Crohn's disease patients: efficacy and side effects

Laura Cantoro

Journal of Crohn s and Colitis

View PDFchevron_right

Thalidomide and Its Analogs as Anticancer Agents

ChunTa Lab

View PDFchevron_right

High Anti-Inflammatory Activity and Low Toxicity of Thalidomide Analogs

Henrique Couto Teixeira

Medicinal Chemistry, 2015

View PDFchevron_right

Immunological consequences of thalidomide treatment in Sjogren's syndrome

Sharon Wahl

Annals of the Rheumatic Diseases, 2006

View PDFchevron_right

Mucosal Healing With Thalidomide in Refractory Crohn’s Disease Patients Intolerant of Anti-TNF-α Drugs

Laura Cantoro, M. Scribano

Journal of Clinical Gastroenterology, 2014

View PDFchevron_right

Thalidomide reduces tumour necrosis factor alpha and interleukin 12 production in patients with chronic active Crohn's disease

jose tavares

Gut, 2002

View PDFchevron_right

Thalidomide Analogs from Diamines: Synthesis and Evaluation as Inhibitors of TNF-α Production

Henrique C Teixeira

CHEMICAL & PHARMACEUTICAL BULLETIN, 2007

View PDFchevron_right